✦ LIBER ✦

Capecitabine in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (39807)

✍ Scribed by Otterson, Gregory A; Herndon, James E; Watson, Dorothy; Green, Mark R; Kindler, Hedy L

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine for malignant mesothelioma:

✍ Kindler, Hedy L.; Millard, Frederick; Herndon II, James E.; Vogelzang, Nicholas 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 86 KB

Vatalanib in malignant mesothelioma: A p

✍ Jahan, Thierry; Gu, Lin; Kratzke, Robert; Dudek, Arkadiusz; Otterson, Gregory A. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 226 KB

Carboplatin in malignant mesothelioma: A

✍ Nicholas J. Vogelzang; Maria Goutsou; Joseph M. Corson; Yasunosuke Suzuki; Steph 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 408 KB

Randomized phase II trial of cisplatin w

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Dihydro-5-azacytidine and cisplatin in t

✍ Brian L. Samuels; James Herndon II; David C. Harmon; Robert Carey; Joseph Aisner 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 3 views

## BACKGROUND. In a prior Cancer and Leukemia Group B (CALGB) Phase II trial of

High-dose doxorubicin, dexrazoxane, and

✍ Kosty, Michael P; Herndon, James E; Vogelzang, Nicholas J; Kindler, Hedy L; Gree 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 86 KB